Modified lysine-mimetic compounds
AssigneeZealand Pharma A/S
InventorsBjarne Due Larsen, Jørgen Søberg Petersen, Ketil Jørgen Haugan, John A. Butera, James K. Hennan, Edward H. Kerns, Evgueni Lvovich Piatnitski
Life of this patent
Estimating the term…
Abstract
Lysine mimetic compounds having useful pharmacological activity such as antiarrhythmic activity and desirable bioavailability properties are disclosed.
Claims6
A method of treating cardiovascular disease selected from atrial fibrillation, atrial flutter, ventricular tachycardia and ventricular fibrillation, comprising administering to a subject a therapeutically effective amount of a compound that is
- or a pharmaceutically acceptable salt thereof.
A method of treating cardiovascular disease selected from atrial fibrillation, atrial flutter, ventricular tachycardia and ventricular fibrillation, comprising administering to a subject a therapeutically effective amount of a compound that is
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.